Company profile LCTX
There is not enough data for Lineage Cell Therapeutics near me to provide analysis
There is not enough data for Lineage Cell Therapeutics near me to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics near me to provide analysis
After 38 days of this quarter the interest is at 93.0. Based on that we can calculate that during remaining 53 days it will total up to 223.0. Lineage Cell Therapeutics stock expected interest is significantly higher compared to previous quarter (+1138.9%) and same quarter last year (+197.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 22 | 127 477.3% QoQ | 126 -0.8% QoQ | 28 -77.8% QoQ |
| 2020 | 64 190.9% YoY 128.6% QoQ | 26 -79.5% YoY -59.4% QoQ | 60 -52.4% YoY 130.8% QoQ | 25 -10.7% YoY -58.3% QoQ |
| 2021 | 146 128.1% YoY 484.0% QoQ | 37 42.3% YoY -74.7% QoQ | 222 270.0% YoY 500.0% QoQ | 151 504.0% YoY -32.0% QoQ |
| 2022 | 154 5.5% YoY 2.0% QoQ | 49 32.4% YoY -68.2% QoQ | 84 -62.2% YoY 71.4% QoQ | 77 -49.0% YoY -8.3% QoQ |
| 2023 | 75 -51.3% YoY -2.6% QoQ | 34 -30.6% YoY -54.7% QoQ | 88 4.8% YoY 158.8% QoQ | 18 -76.6% YoY -79.5% QoQ |
| 2024 | 93 24.0% YoY 416.7% QoQ | - | - | - |
The average 5 years interest of Lineage Cell Therapeutics stock was 6.54 per week. The last year interest of Lineage Cell Therapeutics stock compared to the last 5 years has changed by -15.29%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -9.62%.
There is not enough data for Lineage Cell Therapeutics company news to provide analysis
There is not enough data for Lineage Cell Therapeutics company news to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics company news to provide analysis
There is not enough data for Lineage Cell Therapeutics clinical trials to provide analysis
There is not enough data for Lineage Cell Therapeutics clinical trials to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics clinical trials to provide analysis
There is not enough data for Lineage Cell Therapeutics cell therapy to provide analysis
There is not enough data for Lineage Cell Therapeutics cell therapy to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics cell therapy to provide analysis
There is not enough data for Lineage Cell Therapeutics degenerative diseases to provide analysis
There is not enough data for Lineage Cell Therapeutics degenerative diseases to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics degenerative diseases to provide analysis
There is not enough data for Lineage Cell Therapeutics OpRegen to provide analysis
There is not enough data for Lineage Cell Therapeutics OpRegen to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics OpRegen to provide analysis
There is not enough data for Lineage Cell Therapeutics OPC1 to provide analysis
There is not enough data for Lineage Cell Therapeutics OPC1 to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics OPC1 to provide analysis
There is not enough data for Lineage Cell Therapeutics VAC2 to provide analysis
There is not enough data for Lineage Cell Therapeutics VAC2 to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics VAC2 to provide analysis
Google Trends for Lineage Cell Therapeutics biotechnology
Not enough data for reliable calculations!
There is not enough data for Lineage Cell Therapeutics biotechnology to provide analysis
There is not enough data for Lineage Cell Therapeutics biotechnology to provide correlation calculation
There is not enough data for Lineage Cell Therapeutics biotechnology to provide analysis